Stockreport

Ovid Therapeutics (OVID): Assessing Valuation Following Encouraging OV329 Phase 1 Trial Results [Yahoo! Finance]

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com
PDF GABA-aminotransferase inhibitor that targets drug-resistant epilepsies. The news could influence both sentiment and future expectations. See our latest analysis for Ov [Read more]